バージニアにおけるクローン病の臨床試験
バージニア内の拠点で、クローン病に関する15件の研究が参加者を募集しています。
バージニア内の都市
公式研究テキスト（英語）
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- University of Virginia Health System ( Site 0291), Charlottesville
被験者募集中第3相
全年齢 · 全性別 · 2026/10/02更新 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Richmond VA Medical Center ( Site 5021), Richmond
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/10/02更新 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Emeritas Research Group /ID# 284388, Lansdowne Town Center
- GI Alliance - Richmond /ID# 284244, Richmond
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/02更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Consultants of Southwest Virginia., Roanoke
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Gastroenterology Associates of Tidewater, Chesapeake
- Blue Ridge Medical Research, Lynchburg
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07196722Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- VCU Massey Comprehensive Cancer Center, Richmond
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Blue Ridge Medical Research-Site Number: 8400020, Lynchburg
- Clinical Research Partners-Site Number: 8400080, Richmond
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/23更新 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Gastroenterology Associates of Central Virginia, Lynchburg
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/22更新 · NCT06226883A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Pediatric Specialists of Virginia, Fairfax
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Carilion Children's Tanglewood Center, Roanoke
被験者募集中第3相
2歳以上 · 全性別 · 2026/05/07更新 · NCT05442567Precise Infliximab Exposure and Pharmacodynamic Control
- Children's Specialty Group, Norfolk
被験者募集中第2/3相
6歳〜22歳 · 全性別 · 2026/05/05更新 · NCT05660746A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Carilion Children's Tanglewood Center, Roanoke
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/05/05更新 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Richmond VA Medical Center, Richmond
- Gastroenterology Consultants of Southwest Virginia., Roanoke
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/27更新 · NCT06456593Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
- Resilient Roots: Functional Medicine, Charlottesville
被験者募集中
18歳〜64歳 · 全性別 · 2026/04/16更新 · NCT07524244A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400027, Richmond
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/03/27更新 · NCT06958536ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。